We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Use of selective serotonin re uptake inhibitor medications for the treatment of child and adolescent mental illness.
- Authors
Korczak, Daphne J.
- Abstract
Comprehensive clinical management plans for treating depression or anxiety disorders in children and adolescents frequently include the use of selective serotonin reuptake inhibitor (SSRI) medications. This statement reviews empirical data regarding the effectiveness of specific SSRI medications, monitoring guidelines, and potential adverse effects of SSRI use including risk of suicidality. SSRI medications can be effective in treating child and adolescent depression and anxiety disorders. Untreated depressive illness may be more harmful than appropriate use of SSRI medication. Physicians should ensure careful elicitation and documentation of baseline depressive and anxious symptoms before initiating SSRI medication. Following medication initiation, patients should also be closely monitored for potential adverse effects, including suicidal ideation and behaviour.
- Subjects
CANADA; DETOXIFICATION (Substance abuse treatment); PEDIATRICS; MENTAL illness drug therapy; ANXIETY; DRUG monitoring; FLUOXETINE; EVALUATION of medical care; MEDICAL protocols; PATIENT compliance; RISK assessment; EVIDENCE-based medicine; SEROTONIN uptake inhibitors; PROFESSIONAL practice; SUICIDAL ideation; CITALOPRAM; FLUVOXAMINE; ADOLESCENCE; CHILDREN; SOCIETIES
- Publication
Paediatrics & Child Health (1205-7088), 2013, Vol 18, Issue 9, p487
- ISSN
1205-7088
- Publication type
Article